Revenue Growth - Consolidated revenue for Q2 2024 was $25.8 million, representing a 227% increase compared to $7.9 million in Q2 2023[4] - Total revenues for the first six months of 2024 reached $50.2 million, up 121% from $22.7 million in the same period of 2023[3] - Total revenues for Q2 2024 reached $25,838,000, a significant increase from $7,904,000 in Q2 2023, representing a growth of 227% year-over-year[20] - Intellectual property operations generated revenues of $5,333,000 in Q2 2024, compared to $394,000 in Q2 2023, marking a growth of 1,253%[20] - Energy operations contributed $14,170,000 in revenues for Q2 2024, with no revenues reported in Q2 2023[20] - Benchmark generated approximately $14.2 million in revenue during Q2 2024, contributing significantly to the overall revenue growth[5] Financial Performance - Acacia recorded a GAAP net loss of $8.4 million, or $0.08 diluted net loss per share, for Q2 2024, an improvement from a net loss of $18.8 million, or $0.36 per share, in Q2 2023[7] - The company reported a net loss attributable to Acacia Research Corporation of $8,446,000 for Q2 2024, an improvement from a net loss of $18,779,000 in Q2 2023[25] - Adjusted EBITDA for Q2 2024 was $4.1 million, with a total of $10.4 million for the first half of 2024[4] - Adjusted EBITDA for Q2 2024 was $4,091,000, compared to $6,332,000 in Q1 2024, indicating a decrease in operational performance[28] - Excluding the impact of a $12.9 million accrual related to the AIP Matter, the diluted net loss per share for Q2 2024 would have been $0.02[8] Assets and Liabilities - Cash, cash equivalents, and equity investments measured at fair value totaled $405.2 million at June 30, 2024, compared to $403.2 million at December 31, 2023[10] - Total current assets decreased to $493,934,000 as of June 30, 2024, down from $554,512,000 at the end of 2023[18] - The company’s total liabilities increased significantly to $156,848,000 as of June 30, 2024, compared to $43,936,000 at the end of 2023[18] - Cash and cash equivalents rose to $386,988,000 as of June 30, 2024, up from $340,091,000 at the end of 2023[18] Costs and Expenses - The company incurred total costs and expenses of $30,596,000 in Q2 2024, compared to $20,433,000 in Q2 2023, reflecting a 50% increase[21] Shareholder Information - The company's book value per share increased to $5.95 as of June 30, 2024, compared to $5.90 at December 31, 2023[4] - The weighted average number of shares outstanding increased to 100,079,803 in Q2 2024, compared to 58,408,711 in Q2 2023, indicating a dilution effect on earnings per share[26] Acquisitions - The acquisition of upstream assets in Texas and Oklahoma added approximately 470 operated producing wells and expanded Benchmark's portfolio by about 140,000 net acres[5]

Finding stocks with solid growth potential is essential to take advantage of new chances in today's volatile market. These three exceptional firms each provide solid arguments for considering them as potential stocks to buy to double your money. Knowledge of their market positioning, strategic objectives and financial performance is crucial for assessing their prospects for long-term, steady growth. The foundations of these businesses include leadership in IoT and 5G technologies. There is an exceptional fi ...

Investors with any experience in the world of penny stocks know that risk is real. That risk is higher as the price of shares goes lower. Thus, stocks trading between $5 and $10 are somewhat more stable than their sub-$5 counterparts. Stocks in the $5 to $10 price range have generally passed major tests and become more stable in the process. That's true of all of the shares discussed below. These shares also appear to be poised for breakouts moving forward. Furthermore, all of the stocks discussed below hav ...

Warchi I have recently added a quarter position of Acacia Research (NASDAQ:ACTG) to my value portfolio and will use any dips to add shares until I have a half portfolio position. Acacia Research is a type of BDC (business development company) which seeks to acquire, manage, and eventually sell off small to mid-sized (<$1B) companies in the industrial, energy, technology, and healthcare verticals. It is majority (61%) owned and influenced by Starboard Value LP, an investment adviser (see their website an ...

Finding great opportunities in the middle of market swings is a never-ending task in the dynamic world of stock investing. These three stocks, all under $5, are ripe for a dramatic climb and have the potential to develop significantly. The gold industry, healthcare technology, and specialty finance all present prospects for the stocks. By making smart acquisitions in the oil and gas industry, the first one aims to increase its income sources strategically. The firm demonstrates scalability and a diversified ...

Acacia Research Corporation (NASDAQ:ACTG) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Rob Fink - FNK, IR MJ McNulty - CEO Kirsten Hoover - Interim CFO Conference Call Participants Brett Reiss - Janney Montgomery Scott Adam Eagleston - Formidable Asset Management Operator Good day and welcome to the Acacia Research First Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode. After managements prepared remarks there will be a q ...

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Commission file number: 001-37721 Acacia Research Corporation (Name of registrant as specified in its charter) Delaware 95-4405754 (Stat ...

Revenue and Financial Performance - Total revenues for Q1 2024 were $24.3 million, a significant increase from $14.8 million in Q1 2023, driven by $13.6 million from intellectual property operations[2][4] - Total revenues for Q1 2024 were $24,320 thousand, a significant increase from $14,803 thousand in Q1 2023[17] - Intellectual property operations revenue grew to $13,623 thousand in Q1 2024, compared to $4,176 thousand in Q1 2023[17] - Industrial operations revenue decreased to $8,841 thousand in Q1 2024 from $10,627 thousand in Q1 2023[17] - Energy operations generated $1,856 thousand in revenue in Q1 2024, a new segment not present in Q1 2023[17] - Benchmark Energy generated $1.9 million in revenue in Q1 2024, with no comparable revenue in Q1 2023[2][5] Net Income and Loss - GAAP net loss for Q1 2024 was $0.2 million, or $0.00 per share, compared to a net income of $9.4 million in Q1 2023[2][4] - Net loss attributable to Acacia Research Corporation was $186 thousand in Q1 2024, compared to a net income of $9,447 thousand in Q1 2023[17] - Operating loss improved to $2,087 thousand in Q1 2024 from $9,324 thousand in Q1 2023[17] Cash and Investments - Acacia holds $461.7 million in cash, cash equivalents, and equity investments as of March 31, 2024, up from $403.2 million at the end of 2023[8] - The company has $400 million in cash and marketable securities, net of cash deployed in Benchmark's recent acquisition[1] - Cash and cash equivalents increased to $438,762 thousand as of March 31, 2024, up from $340,091 thousand at the end of 2023[16] Asset and Equity Changes - Book value per share at March 31, 2024 was $5.89, or $5.95 excluding a $6.2 million accrual related to the AIP Matter[2][9] - Accounts receivable decreased to $15,372 thousand as of March 31, 2024, down from $80,555 thousand at the end of 2023[16] - Total assets slightly decreased to $631,725 thousand as of March 31, 2024, from $633,545 thousand at the end of 2023[16] - Equity securities investments showed a change in fair value of $26,701 thousand loss in Q1 2024, compared to a $3,343 thousand gain in Q1 2023[17] Acquisitions and Divestitures - The company completed the sale of Arix Bioscience Plc shares for $57.1 million, realizing a gain of $28.6 million[2] - Benchmark's recent acquisition added 140,000 net acres and 470 operated producing wells in the Western Anadarko Basin[2] Expenses - General and administrative expenses increased to $12.4 million in Q1 2024, up from $12.0 million in Q1 2023[5] Life Sciences Portfolio - Acacia's life sciences portfolio has generated $564.1 million in proceeds from sales and royalties, with remaining positions valued at $25.7 million[7]

Acacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Conference Call March 14, 2024 4:30 PM ET Company Participants Rob Fink - FNK, Investor Relations MJ McNulty - Chief Executive Officer Kirsten Hoover - Interim Chief Financial Officer Conference Call Participants Anthony Stoss - Craig-Hallum Brett Reiss - Janney Montgomery Scott Operator Good afternoon, everyone. And welcome to the Acacia Research Fourth Quarter and Year End 2023 Financial Results Call. At this time, all participants are in a listen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________ FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ___________TO ___________. Commission File Number 001-37721 ______________________ (Exact name of registrant as specified in its charter) Delaware 95-4 ...